# RAPIBLYK
> **NDA217202** · New Drug Application · Sponsor: AOP HLTH US · Approved 2024-11-22
## Drug
- **FDA Application Number:** NDA217202
- **Application type:** New Drug Application
- **Brand name:** RAPIBLYK
- **Generic name:** LANDIOLOL
- **Active ingredients:** LANDIOLOL HYDROCHLORIDE
- **Dosage form:** POWDER
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** AOP HLTH US
- **Manufacturer:** AOP Orphan Pharmaceuticals GmbH
- **First approval:** 2024-11-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217202)
---
*MORVS · CC0 1.0*